Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 12502

1.

Late recurrences in early breast cancer: for whom and how long is endocrine therapy beneficial?

Knauer M, Filipits M, Dubsky P.

Breast Care (Basel). 2014 May;9(2):97-100. doi: 10.1159/000362482. Review.

PMID:
24944551
[PubMed]
2.

Overexpression of the EMT driver brachyury in breast carcinomas: association with poor prognosis.

Palena C, Roselli M, Litzinger MT, Ferroni P, Costarelli L, Spila A, Cavaliere F, Huang B, Fernando RI, Hamilton DH, Jochems C, Tsang KY, Cheng Q, Kim Lyerly H, Schlom J, Guadagni F.

J Natl Cancer Inst. 2014 May 9;106(5). pii: dju054. doi: 10.1093/jnci/dju054.

PMID:
24815864
[PubMed - indexed for MEDLINE]
3.

An unusual case of a borderline Brenner tumor associated with bilateral serous cystadenoma and endometrial carcinoma.

Cruz-Galarza D, Pérez-Rodríguez O, Laboy-Torres J, Gutiérrez-Rivera S.

Bol Asoc Med P R. 2014;106(1):54-6.

PMID:
24791367
[PubMed - indexed for MEDLINE]
4.

Second malignancies after breast cancer: The impact of adjuvant therapy.

Dong C, Chen L.

Mol Clin Oncol. 2014 May;2(3):331-336. Epub 2014 Feb 3. Review.

PMID:
24772296
[PubMed]
Free PMC Article
5.

Axillary dissection versus no axillary dissection in older T1N0 breast cancer patients: 15-year results of trial and out-trial patients.

Martelli G, Boracchi P, Orenti A, Lozza L, Maugeri I, Vetrella G, Agresti R.

Eur J Surg Oncol. 2014 Jul;40(7):805-12. doi: 10.1016/j.ejso.2014.03.029. Epub 2014 Apr 13.

PMID:
24768443
[PubMed - indexed for MEDLINE]
6.

Polyostotic fibrous dysplasia mimicking multiple bone metastases in a patient with ductal carcinoma in situ.

Lee JH, Kim SY, Lee JE, Cho EY, Choi YL, Choi JY, Han SW, Kim SW, Kil WH, Nam SJ.

J Breast Cancer. 2014 Mar;17(1):83-7. doi: 10.4048/jbc.2014.17.1.83. Epub 2014 Mar 28.

PMID:
24744802
[PubMed]
Free PMC Article
7.

CYP2D6 pharmacogenomics of tamoxifen treatment.

Blue Cross Blue Shield Association; Kaiser Foundation Health Plan; Southern California Permanente Medical Group.

Technol Eval Cent Assess Program Exec Summ. 2014 Jan;28(8):1-4. No abstract available.

PMID:
24730084
[PubMed - indexed for MEDLINE]
8.

Tumor heterogeneity confounds and illuminates: a case for Darwinian tumor evolution.

Polyak K.

Nat Med. 2014 Apr;20(4):344-6. doi: 10.1038/nm.3518. No abstract available.

PMID:
24710378
[PubMed - indexed for MEDLINE]
9.

Tools of the trade: individualized breast cancer risk assessment.

Millstine D, David P, Pruthi S.

J Womens Health (Larchmt). 2014 May;23(5):434-6. doi: 10.1089/jwh.2014.4761. Epub 2014 Apr 7. No abstract available.

PMID:
24707809
[PubMed - indexed for MEDLINE]
10.

Primary endocrine therapy as a treatment for older women with operable breast cancer - a comparison of randomised controlled trial and cohort study findings.

Morgan JL, Reed MW, Wyld L.

Eur J Surg Oncol. 2014 Jun;40(6):676-84. doi: 10.1016/j.ejso.2014.02.224. Epub 2014 Mar 16. Review.

PMID:
24703110
[PubMed - indexed for MEDLINE]
11.

Changes in serum hydroxyvitamin D levels of breast cancer patients during tamoxifen treatment or chemotherapy in premenopausal breast cancer patients.

Kim HJ, Koh BS, Yu JH, Lee JW, Son BH, Kim SB, Ahn SH.

Eur J Cancer. 2014 May;50(8):1403-11. doi: 10.1016/j.ejca.2014.02.026. Epub 2014 Apr 1.

PMID:
24703104
[PubMed - indexed for MEDLINE]
12.

Estrogen receptor, Progesterone receptor, HER2 status and Ki67 index and responsiveness to adjuvant tamoxifen in postmenopausal high-risk breast cancer patients enrolled in the DBCG 77C trial.

Knoop AS, Lænkholm AV, Jensen MB, Nielsen KV, Andersen J, Nielsen D, Ejlertsen B; Danish Breast Cancer Cooperative Group.

Eur J Cancer. 2014 May;50(8):1412-21. doi: 10.1016/j.ejca.2014.02.022. Epub 2014 Mar 24.

PMID:
24675287
[PubMed - indexed for MEDLINE]
13.

Smaller reduction in 3D breast density associated with subsequent cancer recurrence in patients with breast cancer receiving adjuvant tamoxifen therapy.

Kim JY, Cho N, Jeyanth JX, Kim WH, Lee SH, Gweon HM, Moon WK.

AJR Am J Roentgenol. 2014 Apr;202(4):912-21. doi: 10.2214/AJR.13.11109.

PMID:
24660724
[PubMed - indexed for MEDLINE]
14.

Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials.

EBCTCG (Early Breast Cancer Trialists' Collaborative Group), McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, Gray R, Mannu G, Peto R, Whelan T, Wang Y, Wang Z, Darby S.

Lancet. 2014 Jun 21;383(9935):2127-35. doi: 10.1016/S0140-6736(14)60488-8. Epub 2014 Mar 19.

PMID:
24656685
[PubMed - indexed for MEDLINE]
Free Article
15.

External validity of a trial comprised of elderly patients with hormone receptor-positive breast cancer.

van de Water W, Kiderlen M, Bastiaannet E, Siesling S, Westendorp RG, van de Velde CJ, Nortier JW, Seynaeve C, de Craen AJ, Liefers GJ.

J Natl Cancer Inst. 2014 Apr;106(4):dju051. doi: 10.1093/jnci/dju051. Epub 2014 Mar 19.

PMID:
24647464
[PubMed - indexed for MEDLINE]
16.

How often did Belgian physicians co-prescribe tamoxifen with strong CYP2D6 inhibitors over the last 6 years?

Dieudonné AS, De Nys K, Casteels M, Wildiers H, Neven P.

Acta Clin Belg. 2014 Jan-Feb;69(1):47-52. doi: 10.1179/0001551213Z.00000000017.

PMID:
24635399
[PubMed - indexed for MEDLINE]
17.

Adjuvant endocrine therapy for breast cancer: how long is long enough?

Jankowitz RC, Davidson NE.

Oncology (Williston Park). 2013 Dec;27(12):1210-6, 1224. Review.

PMID:
24624537
[PubMed - indexed for MEDLINE]
18.

Case of uterine papillary serous carcinoma following tamoxifen treatment that could not be diagnosed during screening.

Maenaka T, Egawa-Takata T, Hisamoto K, Kunishige I, Nishio Y, Tsujimoto M.

J Obstet Gynaecol Res. 2014 May;40(5):1450-4. doi: 10.1111/jog.12317. Epub 2014 Mar 9.

PMID:
24606575
[PubMed - in process]
19.

Treatment of ductal carcinoma in situ: an uncertain harm-benefit balance.

[No authors listed]

Prescrire Int. 2013 Dec;22(144):298-303. Review.

PMID:
24600734
[PubMed - indexed for MEDLINE]
20.

Budget woes hinder clinical-trials network.

Ledford H.

Nature. 2014 Mar 6;507(7490):21. doi: 10.1038/507021a. No abstract available.

PMID:
24598621
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk